Keyphrases
Psilocybin
100%
Serotonin 2A Receptor (5-HT2AR)
54%
Healthy Individuals
47%
Psilocin
35%
Psychedelics
28%
Seasonal Affective Disorder
28%
Functional Connectivity
26%
Amygdala
25%
Healthy Volunteers
25%
Receptor Binding
21%
Emotional Faces
19%
5-HTTLPR
19%
Serum Serotonin
19%
Mystical Experience
18%
Threat-related
17%
Light Intervention
17%
Positron Emission Tomography Study
17%
Brain Networks
17%
Receptor Occupancy
17%
Bright Light
17%
Resting-state Functional Connectivity (rs-FC)
14%
Negatively Associated
12%
Default Mode Network
11%
Psychedelic Experience
11%
Neocortical
10%
Mindfulness
10%
Neuroticism
10%
Positron Emission Tomography
10%
Neural Pathways
10%
Subjective Effects
9%
Symptom Severity
9%
Mystical Experience Questionnaire
9%
Chronic Cluster Headache
8%
Network Response
8%
In-text References
8%
Attack Frequency
8%
Inflammatory Biomarkers
8%
Network Segregation
8%
Trait Mindfulness
8%
Headache Attacks
8%
Subacute Effects
8%
Frequency Reduction
8%
Amygdala Circuit
8%
Dose Effect
8%
Risk Response
8%
Corticolimbic
8%
Openness to Experience
8%
Network Integrity
8%
Time-varying Functional Connectivity
8%
Striatal
8%
Neuroscience
Psilocybin
77%
5-HT2A Receptor
40%
Seasonal Affective Disorder
36%
Amygdala
32%
Functional Connectivity
29%
Psychotomimetic
26%
5-HTTLPR
26%
Psilocin
26%
Positron Emission Tomography
25%
Serotonin Transporter
22%
Receptor Binding
21%
Mindfulness
19%
Face
18%
Brain Network
17%
Serotonin
16%
Mood Disorder
13%
Resting-State Functional Connectivity
13%
Neural Pathway
12%
Prefrontal Cortex
12%
Default Mode Network
11%
Functional Magnetic Resonance Imaging
11%
Neuroticism
10%
DASB
9%
Receptor Occupancy
8%
Personality Traits
7%
Depression
6%
Serotonergic Psychedelic
6%
Altanserin
5%
Fluorine-18
5%